OLLO PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
OLLO PHARMA
Largest movements
- Current investments +€122,273
up €122,273 (+12.9%), from €946,851 to €1.1m
- Cash +€119,259
up €119,259 (+19.3%), from €616,372 to €735,631
mainly Net result for the year (+€322,041) and Other debts (+€216,522)
- Receivables within one year +€83,699
up €83,699 (+47.8%), from €175,179 to €258,878
of which Other amounts receivable: +€66,072
- Tangible fixed assets -€58,098
down €58,098 (-15.3%), from €379,310 to €321,212
of which Land and buildings: -€48,370
- Other debts +€216,522
up €216,522 (+251.8%), from €85,976 to €302,498
- Reserves +€165,000
up €165,000 (+11.3%), from €1.5m to €1.6m
- Debts after one year -€63,581
down €63,581 (-21.3%), from €298,102 to €234,521
- Trade debts -€43,229
down €43,229 (-16.9%), from €255,890 to €212,660
- Gross operating margin -€44,592
down €44,592 (-5.0%), from €889,093 to €844,501
- Staff costs +€34,717
up €34,717 (+10.9%), from €317,185 to €351,902
- Financial income -€32,635
down €32,635 (-54.4%), from €59,979 to €27,344
- Taxes -€14,634
down €14,634 (-12.3%), from €118,724 to €104,090
- Depreciation -€11,773
down €11,773 (-13.9%), from €84,907 to €73,134
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,426,140 | €2,656,235 | +€230,096 | +9.5% |
| Fixed assets | 21/28 | €394,346 | €321,212 | -€73,134 | -18.5% |
| Intangible fixed assets | 21 | €15,036 | - | -€15,036 | |
| Tangible fixed assets | 22/27 | €379,310 | €321,212 | -€58,098 | -15.3% |
| Land and buildings | 22 | €353,671 | €305,301 | -€48,370 | -13.7% |
| Furniture and vehicles | 24 | €25,639 | €15,911 | -€9,728 | -37.9% |
| Current assets | 29/58 | €2,031,794 | €2,335,024 | +€303,230 | +14.9% |
| Stocks and contracts in progress | 3 | €290,719 | €267,789 | -€22,931 | -7.9% |
| Stocks | 30/36 | €290,719 | €267,789 | -€22,931 | -7.9% |
| Amounts receivable within one year | 40/41 | €175,179 | €258,878 | +€83,699 | +47.8% |
| Trade receivables | 40 | €169,012 | €186,639 | +€17,627 | +10.4% |
| Other amounts receivable | 41 | €6,168 | €72,240 | +€66,072 | +1071.3% |
| Current investments | 50/53 | €946,851 | €1,069,124 | +€122,273 | +12.9% |
| Cash at bank and in hand | 54/58 | €616,372 | €735,631 | +€119,259 | +19.3% |
| Deferred charges and accrued income | 490/1 | €2,672 | €3,602 | +€930 | +34.8% |
| Total equity and liabilities | 10/49 | €2,426,140 | €2,656,235 | +€230,096 | +9.5% |
| Equity | 10/15 | €1,586,320 | €1,750,695 | +€164,375 | +10.4% |
| Contributions | 10/11 | €125,000 | €125,000 | = | 0.0% |
| Reserves | 13 | €1,460,500 | €1,625,500 | +€165,000 | +11.3% |
| Distributable reserves | 133 | €1,460,500 | €1,625,500 | +€165,000 | +11.3% |
| Profit (loss) carried forward | 14 | €820 | €195 | -€625 | -76.2% |
| Amounts payable | 17/49 | €839,819 | €905,540 | +€65,721 | +7.8% |
| Amounts payable after more than one year | 17 | €298,102 | €234,521 | -€63,581 | -21.3% |
| Financial debts | 170/4 | €298,102 | €234,521 | -€63,581 | -21.3% |
| Amounts payable within one year | 42/48 | €526,545 | €661,672 | +€135,127 | +25.7% |
| Current portion of amounts payable after more than one year | 42 | €83,736 | €63,581 | -€20,155 | -24.1% |
| Trade debts | 44 | €255,890 | €212,660 | -€43,229 | -16.9% |
| Suppliers | 440/4 | €255,890 | €212,660 | -€43,229 | -16.9% |
| Taxes, remuneration and social security | 45 | €100,943 | €82,932 | -€18,011 | -17.8% |
| Taxes | 450/3 | €36,225 | €9,076 | -€27,149 | -74.9% |
| Remuneration and social security | 454/9 | €64,719 | €73,856 | +€9,138 | +14.1% |
| Other amounts payable | 47/48 | €85,976 | €302,498 | +€216,522 | +251.8% |
| Accrued charges and deferred income | 492/3 | €15,172 | €9,348 | -€5,825 | -38.4% |
| Remuneration, social security and pensions | 62 | €317,185 | €351,902 | +€34,717 | +10.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €84,907 | €73,134 | -€11,773 | -13.9% |
| Other operating charges | 640/8 | €4,935 | €4,554 | -€381 | -7.7% |
| Non-recurring operating charges | 66A | €30 | - | -€30 | |
| Gross operating margin | 9900 | €889,093 | €844,501 | -€44,592 | -5.0% |
| Operating profit (loss) | 9901 | €482,036 | €414,912 | -€67,124 | -13.9% |
| Financial income | 75/76B | €59,979 | €27,344 | -€32,635 | -54.4% |
| Recurring financial income | 75 | €59,979 | €27,344 | -€32,635 | -54.4% |
| Financial charges | 65/66B | €24,643 | €16,124 | -€8,518 | -34.6% |
| Recurring financial charges | 65 | €24,643 | €16,010 | -€8,633 | -35.0% |
| Non-recurring financial charges | 66B | - | €115 | +€115 | |
| Profit (loss) for the period before taxes | 9903 | €517,372 | €426,131 | -€91,241 | -17.6% |
| Income taxes | 67/77 | €118,724 | €104,090 | -€14,634 | -12.3% |
| Profit (loss) for the period | 9904 | €398,648 | €322,041 | -€76,607 | -19.2% |
| Profit (loss) for the period to be appropriated | 9905 | €398,648 | €322,041 | -€76,607 | -19.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.